Focal neuroleptization: an approach to optimal dosing for initial and continuing therapy.

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Long-term neuroleptic therapy raises concerns about cumulative side effects.
• There is a need for strategies to ensure the lowest effective medication levels.
• Current treatment goals must align with medication dosing practices.

Purpose of the Study:

• To reassess rapid neuroleptization techniques.
• To redefine rapid neuroleptization as focal neuroleptization.
• To emphasize the relationship between acute and chronic neuroleptic therapy.

Main Methods:

• Reviewed historical rapid neuroleptization techniques.
• Introduced and defined the concept of focal neuroleptization.
• Compared high-dose (e.g., >10-20 mg/day haloperidol) with low-dose neuroleptic therapy.

Main Results:

• Focal neuroleptization minimizes risks associated with rapid neuroleptization, such as unnecessarily high acute doses.
• Studies show no significant differences in symptom remission speed or completeness between high-dose and low-dose therapy.
• High acute doses complicate the achievement of effective low-dose maintenance therapy.

Conclusions:

• Physicians should re-evaluate high-dose rapid neuroleptization approaches.
• The objective is to achieve the lowest effective neuroleptic dose in both acute and maintenance phases.
• Focal neuroleptization integrates rapid symptom reduction, individualized treatment, and low-dose maintenance.